|
|
News Breaks | | | | December 19, 2012 | | 08:01 EDT |  | ANX | Adventrx to initiate Phase 3 study of ANX-188
Adventrx announced that ANX-188 drug product for use in the phase 3 clinical study of ANX-188, manufactured using the company's proprietary purification process, has passed quality control release specifications at Patheon, the company's contract manufacturer, and currently is in the quality assurance release process. The study has been approved by multiple institutional review boards and initiation of the study is expected in approximately six weeks. | |
|
News For ANX From The Last 14 Days Check below for free stories on ANX the last two weeks. |
|
|
| There are no results for ANX |
|
|
|
|
|
|
